Molecular Medicine Tri-Conference 2014 - Complimentary Hall Passes Available

BOSTON - Jan. 31, 2014 - PRLog -- The 21st Molecular Medicine Tri-Conference has opened registration for free exhibit hall and keynote presentation passes for the 2014 exhibition, taking place February 10-12 in San Francisco, CA.  Attracting more than 3,000 scientific professionals annually, the event equips teams with the latest developments in Molecular Medicine, including Clinical, Bioinformatics, Diagnostics and Cancer Research.

The complimentary hall pass provides visitors with access to 200 exhibiting companies, more than 170 research posters, a new products showcase, vendor theater presentations, the annual networking reception and the highly anticipated keynote presentations.

The 2014 keynote presentations will be delivered by David R. Gandara, M.D., Director, Thoracic Oncology Program; Professor and Senior Advisor to Director, UC Davis Cancer Center; Kimberly L. Blackwell, M.D., Professor of Medicine, Assistant Professor of Radiation Oncology; Director, Breast Cancer Program, Duke Cancer Institute; and C. Thomas Caskey, M.D., FACP, FRSC, Professor, Department of Molecular and Human Genetics, Baylor College of Medicine.

The 2014 Emerging Technologies and Industry Perspectives Panel includes Michael H. A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University of Toronto; Scientist, Ontario Cancer Institute; Bernard F. Andruss, Ph.D., Vice President, CDx Development & Regulatory Affairs, Asuragen, Inc.; Rudi Pauwels, Ph.D., Executive Chairman & CEO, Biocartis; Yan Yang, Ph.D., Director, Lab Operations, in vivo Services, The Jackson Laboratory; Jeremy Bridge-Cook, Ph.D., Senior Vice President, Research & Development, Luminex; David C. Duffy, Ph.D., CTO, Quanterix Corporation; and Gary Kennedy, CEO, Remedy Informatics.

Visitors also gain admission to their choice of 34 interactive breakout sessions, providing the opportunity to discuss pressing questions across specialized topics, such as Data Integration Today, Metastatic Tumor Models, PCR Quality Control and the Future of Prenatal Genomic Testing.

Complimentary hall passes are available until January 31, 2014.  Reserve yours today at http://www.triconference.com/hallpass

About Molecular Medicine Tri-Conference
Cambridge Healthtech Institute's flagship event, Molecular Medicine Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints. Spanning six days, the 2014 Tri-Conference includes 6 Concurrent Symposia, 20 short courses, 15 conference programs and a three-day exhibition.

About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.